Salvage Peanut Oral Immunotherapy Study

Phase 1/2 Completed 15 enrolled University of North Carolina, Chapel Hill

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to study the safety of rescue peanut oral immunotherapy followed by the introduction of dietary peanut for patients with peanut allergy who have lost desensitization during a peanut immunotherapy trial.

Timeline

Start: 2018-01-03
Primary completion: 2021-11-23
Completion: 2021-11-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Peanut Flour	Protein / enzyme biologic	300 mg	Oral

Salvage Peanut Oral Immunotherapy Study

Summary

Timeline

Drugs

Indications